The purpose of this clinical research study is to learn if the study drug entecavir will prevent the recurrence of hepatitis B virus (HBV) in participants who receive an orthotopic liver transplant (OLT) due to HBV infection.
Tablets, Oral, 1 mg, once daily, up to 72 weeks
Buenos Aires, Buenos Aires, Argentina